Literature DB >> 32243509

Immunoglobulin variable domain high-throughput sequencing reveals specific novel mutational patterns in POEMS syndrome.

Sébastien Bender1,2,3, Vincent Javaugue1,2,4, Alexis Saintamand1, Maria Victoria Ayala1, Mehdi Alizadeh5, Matthieu Filloux3, Virginie Pascal3, Nathalie Gachard1,6, David Lavergne2, Fabienne Auroy2, Michel Cogné1, Frank Bridoux1,2,4, Christophe Sirac1,2, Arnaud Jaccard1,2,7.   

Abstract

Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome is a rare multisystem disease resulting from an underlying plasma cell (PC) dyscrasia. The pathophysiology of the disease remains unclear, but the role of the monoclonal immunoglobulin (Ig) light chain (LC) is strongly suspected because of the highly restrictive usage of 2 λ variable (V) domains (IGLV1-40 and IGLV1-44) and the general improvement of clinical manifestations after PC clone-targeted treatment. However, the diagnostic value of Ig LC sequencing, especially in the case of incomplete forms of the disease, remains to be determined. Using a sensitive high-throughput Ig repertoire sequencing on RNA (rapid amplification of cDNA ends-based repertoire sequencing [RACE-RepSeq]), we detected a λ LC monoclonal expansion in the bone marrow (BM) of 83% of patients with POEMS syndrome, including some in whom BM tests routinely performed to diagnose plasma cell dyscrasia failed to detect λ+ monoclonal PCs. Twenty-four (83%) of the 29 LC clonal sequences found were derived from the IGLV1-40 and IGLV1-44 germline genes, as well as 2 from the closely related IGLV1-36 gene, and all were associated with an IGLJ3*02 junction (J) gene, confirming the high restriction of VJ region usage in POEMS syndrome. RACE-RepSeq VJ full-length sequencing additionally revealed original mutational patterns, the strong specificity of which might crucially help establish or eliminate the diagnosis of POEMS syndrome in uncertain cases. Thus, RACE-RepSeq appears as a sensitive, rapid, and specific tool to detect low-abundance PC clones in BM and assign them to POEMS syndrome, with all the consequences for therapeutic options.
© 2020 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32243509      PMCID: PMC8209552          DOI: 10.1182/blood.2019004197

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  39 in total

Review 1.  IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains.

Authors:  Marie-Paule Lefranc; Christelle Pommié; Manuel Ruiz; Véronique Giudicelli; Elodie Foulquier; Lisa Truong; Valérie Thouvenin-Contet; Gérard Lefranc
Journal:  Dev Comp Immunol       Date:  2003-01       Impact factor: 3.636

2.  The repertoire of λ light chains causing predominant amyloid heart involvement and identification of a preferentially involved germline gene, IGLV1-44.

Authors:  Vittorio Perfetti; Giovanni Palladini; Simona Casarini; Valentina Navazza; Paola Rognoni; Laura Obici; Rosangela Invernizzi; Stefano Perlini; Catherine Klersy; Giampaolo Merlini
Journal:  Blood       Date:  2011-11-08       Impact factor: 22.113

3.  IMGT(®) tools for the nucleotide analysis of immunoglobulin (IG) and T cell receptor (TR) V-(D)-J repertoires, polymorphisms, and IG mutations: IMGT/V-QUEST and IMGT/HighV-QUEST for NGS.

Authors:  Eltaf Alamyar; Patrice Duroux; Marie-Paule Lefranc; Véronique Giudicelli
Journal:  Methods Mol Biol       Date:  2012

Review 4.  Dangerous small B-cell clones.

Authors:  Giampaolo Merlini; Marvin J Stone
Journal:  Blood       Date:  2006-06-22       Impact factor: 22.113

5.  The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome.

Authors:  Anita D'Souza; Suzanne R Hayman; Francis Buadi; Michelle Mauermann; Martha Q Lacy; Morie A Gertz; Robert A Kyle; Shaji Kumar; Philip R Greipp; John A Lust; Stephen J Russell; Steven Zeldenrust; David Dingli; Thomas E Witzig; S Vincent Rajkumar; Angela Dispenzieri
Journal:  Blood       Date:  2011-08-31       Impact factor: 22.113

6.  Unbiased RACE-Based Massive Parallel Surveys of Human IgA Antibody Repertoires.

Authors:  Hanane El Bannoudi; Céline Anquetil; Marc J Braunstein; Sergei L Kosakovsky Pond; Gregg J Silverman
Journal:  Methods Mol Biol       Date:  2017

7.  The tropism of organ involvement in primary systemic amyloidosis: contributions of Ig V(L) germ line gene use and clonal plasma cell burden.

Authors:  R L Comenzo; Y Zhang; C Martinez; K Osman; G A Herrera
Journal:  Blood       Date:  2001-08-01       Impact factor: 22.113

8.  RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1alpha.

Authors:  Ye V Liu; Jin H Baek; Huafeng Zhang; Roberto Diez; Robert N Cole; Gregg L Semenza
Journal:  Mol Cell       Date:  2007-01-26       Impact factor: 17.970

9.  Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T Cells.

Authors:  Michael Boice; Darin Salloum; Frederic Mourcin; Viraj Sanghvi; Rada Amin; Elisa Oricchio; Man Jiang; Anja Mottok; Nicolas Denis-Lagache; Giovanni Ciriello; Wayne Tam; Julie Teruya-Feldstein; Elisa de Stanchina; Wing C Chan; Sami N Malek; Daisuke Ennishi; Renier J Brentjens; Randy D Gascoyne; Michel Cogné; Karin Tarte; Hans-Guido Wendel
Journal:  Cell       Date:  2016-09-29       Impact factor: 41.582

10.  IMGT/HighV QUEST paradigm for T cell receptor IMGT clonotype diversity and next generation repertoire immunoprofiling.

Authors:  Shuo Li; Marie-Paule Lefranc; John J Miles; Eltaf Alamyar; Véronique Giudicelli; Patrice Duroux; J Douglas Freeman; Vincent D A Corbin; Jean-Pierre Scheerlinck; Michael A Frohman; Paul U Cameron; Magdalena Plebanski; Bruce Loveland; Scott R Burrows; Anthony T Papenfuss; Eric J Gowans
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more
  6 in total

Review 1.  Strategies for Immunomonitoring after Vaccination and during Infection.

Authors:  Lucille Adam; Pierre Rosenbaum; Olivia Bonduelle; Behazine Combadière
Journal:  Vaccines (Basel)       Date:  2021-04-09

Review 2.  Multicentric Castleman disease and the evolution of the concept.

Authors:  Ting Zhou; Hao-Wei Wang; Stefania Pittaluga; Elaine S Jaffe
Journal:  Pathologica       Date:  2021-10

3.  POEMS Syndrome with Biclonal Gammopathy and Renal Involvement.

Authors:  Kohei Inoue; Kei Nagai; Tsuyoshi Tsukada; Mamiko Iwase; Akiko Sakata; Atsushi Ueda; Kunihiro Yamagata
Journal:  Intern Med       Date:  2022-03-12       Impact factor: 1.282

4.  Prognostic value of 12 m7G methylation-related miRNA markers and their correlation with immune infiltration in breast cancer.

Authors:  Wenchuan Zhang; Shuwan Zhang; Zhe Wang
Journal:  Front Oncol       Date:  2022-08-05       Impact factor: 5.738

5.  A novel pyroptosis-related indicator of immune infiltration features and prognosis in breast cancer.

Authors:  Cheng Wang; Liyong Zhang; Lin Ren; Guozhi Zhang; Andi Wan; Siyi Xiong; Hao Tian; Zaihui Peng; Tingting Zhao; Pingping Gao; Na Sun; Yi Zhang; Xiaowei Qi
Journal:  Front Oncol       Date:  2022-09-07       Impact factor: 5.738

Review 6.  Randall-Type Monoclonal Immunoglobulin Deposition Disease: New Insights into the Pathogenesis, Diagnosis and Management.

Authors:  Camille Cohen; Florent Joly; Audrey Sibille; Vincent Javaugue; Estelle Desport; Jean-Michel Goujon; Guy Touchard; Jean-Paul Fermand; Christophe Sirac; Frank Bridoux
Journal:  Diagnostics (Basel)       Date:  2021-03-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.